T-cell protein tyrosine phosphatase (TC-PTP), encoded by the PTPN2 gene, is a critical enzyme in the regulation of various cellular processes, including cell growth, differentiation, cycle control, and apoptotic pathways. It is ubiquitously expressed in human tissues, with two isoforms that are distributed differently within the cell: one localized in the endoplasmic reticulum and the other in the nucleus. TC-PTP functions by dephosphorylating tyrosine residues on target proteins, thus modulating the activity of these proteins. It plays a significant role in the negative regulation of insulin signaling and cytokine signaling pathways, including those mediated by the Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway. By controlling the phosphorylation status of key signaling molecules, TC-PTP serves as an essential regulator of intracellular signal transduction, ensuring that cellular responses to external stimuli are appropriately modulated. Its activity is crucial for maintaining cellular homeostasis and for the fine-tuning of immune responses, highlighting its significance in both physiological and pathological contexts.
The inhibition of TC-PTP represents a complex interplay of molecular mechanisms aimed at disrupting its phosphatase activity, thereby influencing the phosphorylation dynamics within the cell. Inhibitors of TC-PTP can act by directly binding to the catalytic site of the enzyme, blocking its ability to interact with substrate proteins. This results in the sustained phosphorylation of proteins involved in signaling pathways regulated by TC-PTP, such as those governing insulin response and cytokine signaling. Additionally, inhibitory mechanisms may involve the modulation of the expression levels or stability of TC-PTP, indirectly affecting its activity. By altering the activity of TC-PTP, these inhibitors can impact a wide array of cellular processes, leading to alterations in cell growth, apoptosis, and immune responses. Understanding the specific mechanisms by which TC-PTP is inhibited offers valuable insights into how modulation of tyrosine phosphorylation can influence cellular signaling pathways and biological outcomes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
NSC 87877 | 56990-57-9 | sc-204139 | 50 mg | $137.00 | 12 | |
NSC-87877 is a selective inhibitor of TC-PTP that has shown potential in research models for its anti-inflammatory effects and modulation of immune responses. | ||||||
Compound 101 | 161125-36-6 | sc-507528 | 5 mg | $108.00 | ||
Cmpd101 is a TC-PTP inhibitor that has been studied for its effects on glucose metabolism and insulin sensitivity. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A is primarily known as an immunosuppressive agent used to prevent organ transplant rejection, but it has also been found to inhibit TC-PTP activity. | ||||||
Ursolic Acid | 77-52-1 | sc-200383 sc-200383A | 50 mg 250 mg | $56.00 $180.00 | 8 | |
Ursolic acid, a natural compound found in certain plants, has been investigated for its potential as a TC-PTP inhibitor. | ||||||